We are live on ! Find out more
VMD icon

Viemed Healthcare

116 hedge funds and large institutions have $167M invested in Viemed Healthcare in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 29

27% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 15

4% more funds holding

Funds holding: 112116 (+4)

1.65% more ownership

Funds ownership: 63.84%65.49% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

29% less capital invested

Capital invested by funds: $233M → $167M (-$66.8M)

92% less call options, than puts

Call options by funds: $7K | Put options by funds: $89K

Holders
116
Holders Change
+4
Holders Change %
+3.57%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
19
Increased
53
Reduced
29
Closed
15
Calls
$7K
Puts
$89K
Net Calls
-$82K
Net Calls Change
-$218K
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
1
Thrivent Financial for Lutherans
Minnesota
$22.3M +$45.1K +5,985 +0.2%
BlackRock
2
BlackRock
New York
$19.1M +$2.58M +342,520 +13%
Vanguard Group
3
Vanguard Group
Pennsylvania
$11.7M -$11.7K -1,548 -0.1%
FCM
4
Forager Capital Management
Alabama
$11.2M
WA
5
Wasatch Advisors
Utah
$10.1M +$2.88M +382,673 +33%
NCM
6
Nantahala Capital Management
Connecticut
$9.4M -$867K -115,000 -7%
AIC
7
AWM Investment Company
New York
$8.45M -$1.06M -140,345 -10%
KLC
8
Kent Lake Capital
Nevada
$7.46M +$4.14M +549,644 +93%
PAIM
9
Punch & Associates Investment Management
Minnesota
$5.21M +$379K +50,340 +7%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$5.08M +$180K +23,922 +3%
Goldman Sachs
11
Goldman Sachs
New York
$4.76M +$838K +111,158 +18%
State Street
12
State Street
Massachusetts
$4.17M +$253K +33,639 +6%
Renaissance Technologies
13
Renaissance Technologies
New York
$2.87M +$1.11M +147,900 +51%
PCMI
14
Paradigm Capital Management Inc
New York
$2.62M +$603K +80,000 +25%
TAM
15
Tocqueville Asset Management
New York
$2.5M
RA
16
Raffles Associates
New York
$2.38M +$113K +15,000 +4%
BA
17
Bard Associates
Illinois
$2.24M -$6.97K -925 -0.3%
CSC
18
Cove Street Capital
California
$2.12M -$4.3M -570,889 -64%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$2.01M -$63.4K -8,408 -3%
Northern Trust
20
Northern Trust
Illinois
$1.82M -$54.2K -7,192 -3%
PAM
21
Panagora Asset Management
Massachusetts
$1.78M +$21.9K +2,904 +1%
Morgan Stanley
22
Morgan Stanley
New York
$1.77M -$339K -44,951 -14%
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$1.68M -$1.49M -197,136 -43%
ACA
24
Apis Capital Advisors
New York
$1.54M +$1.16M +154,400 +193%
PM
25
Penbrook Management
New York
$1.52M +$1.23M +162,670 +236%

VMD Hedge Fund Activity: Q2 2024 in Review

116 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q2 2024, worth a combined $167M — down 29% from $233M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new VMD positions and 15 closed out — a net gain of 4 holders — while 53 added to existing stakes and 29 trimmed.

The largest buyer was Kent Lake Capital, adding an estimated $4.14M. The largest seller was Cove Street Capital, cutting an estimated $4.3M.

  • 116 institutional investors held Viemed Healthcare (VMD) as of Q2 2024, up from 112 in Q1 2024.
  • Funds reported $167M of Viemed Healthcare stock for Q2 2024, down 29% quarter-over-quarter.
  • 19 funds opened new Viemed Healthcare positions in Q2 2024 and 15 closed out, a net change of +4 holders.
  • The largest Viemed Healthcare buyer in Q2 2024 was Kent Lake Capital, an estimated $4.14M added.
  • The largest Viemed Healthcare seller in Q2 2024 was Cove Street Capital, an estimated $4.3M sold.

Based on aggregated 13F filings for Q2 2024.